| 标题 |
Efficacy and safety of limertinib versus gefitinib as first-line treatment for locally advanced or metastatic non-small-cell lung cancer with EGFR-sensitising mutation: a randomised, double-blind, double-dummy, phase 3 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet. Respiratory medicine 作者:Shi Y; Wu L; Ji Y; Chen G; Li B; et al 出版日期:2025/08/01 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)